Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 5.53 is in line with its 5-year average of 5.58, near the low end of its 5-year range (0.25–29.06).
As of the fiscal period ended Tuesday, June 30, 2026. 9.87% below its 12-month average of 6.14.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.53.
QUICK RATIO (ACID-TEST)
5.53
QUICK RATIO (ACID-TEST) AVG TTM
6.14
QUICK RATIO (ACID-TEST) AVG 3Y
5.18
QUICK RATIO (ACID-TEST) AVG 5Y
5.58
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-9.87%
CURRENT VS 3Y AVG
+6.80%
CURRENT VS 5Y AVG
-0.83%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+64.96%
vs the sector median at left
RenovoRx, Inc.
Market Cap
$62.62M
Quick Ratio (Acid-Test)
5.53
TTM Avg
6.14
3Y Avg
5.18
5Y Avg
5.58
Market Cap
$62.78M
Quick Ratio (Acid-Test)
1.51
TTM Avg
1.60
3Y Avg
1.72
5Y Avg
2.07
Market Cap
$63.02M
Quick Ratio (Acid-Test)
0.97
TTM Avg
1.07
3Y Avg
1.19
5Y Avg
1.33
Market Cap
$63.78M
Quick Ratio (Acid-Test)
9.90
TTM Avg
11.46
3Y Avg
13.71
5Y Avg
15.39
Market Cap
$64.18M
Quick Ratio (Acid-Test)
0.27
TTM Avg
0.22
3Y Avg
0.21
5Y Avg
0.99
Market Cap
$60.42M
Quick Ratio (Acid-Test)
3.15
TTM Avg
4.21
3Y Avg
4.66
5Y Avg
4.26
Market Cap
$60.02M
Quick Ratio (Acid-Test)
1.35
TTM Avg
1.97
3Y Avg
5.50
5Y Avg
8.52
Market Cap
$65.85M
Quick Ratio (Acid-Test)
33.15
TTM Avg
13.79
3Y Avg
28.68
5Y Avg
44.67
Market Cap
$65.86M
Quick Ratio (Acid-Test)
3.50
TTM Avg
1.85
3Y Avg
1.22
5Y Avg
3.58
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| RenovoRx, Inc. (RNXT) | $62.62M | 5.53 | 6.14 | 5.18 | 5.58 |
| Heron Therapeutics, Inc. (HRTX)vs › | $62.78M | 1.51 | 1.60 | 1.72 | 2.07 |
| InterCure Ltd. (INCR)vs › | $63.02M | 0.97 | 1.07 | 1.19 | 1.33 |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | 9.90 | 11.46 | 13.71 | 15.39 |
| Alps Group Inc (ALPS)vs › | $64.18M | 0.27 | 0.22 | 0.21 | 0.99 |
| Fractyl Health, Inc. (GUTS)vs › | $60.42M | 3.15 | 4.21 | 4.66 | 4.26 |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | 1.35 | 1.97 | 5.50 | 8.52 |
| XBiotech Inc. (XBIT)vs › | $65.85M | 33.15 | 13.79 | 28.68 | 44.67 |
| Cingulate Inc. (CING)vs › | $65.86M | 3.50 | 1.85 | 1.22 | 3.58 |
| Gossamer Bio, Inc. (GOSS)vs › | $65.87M | 0.53 | 4.76 | 5.20 | 7.10 |
Quick Ratio
5.53
Excludes inventory
Current Ratio
5.74
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 5.53 |
| 2026-03-31 | 6.95 |
| 2025-12-31 | 3.93 |
| 2025-09-30 | 5.68 |
| 2025-06-30 | 8.61 |
| 2025-03-31 | 9.07 |
| 2024-12-31 | 4.10 |
| 2024-09-30 | 5.66 |
| 2024-06-30 | 9.16 |
| 2024-03-31 | 1.54 |
| 2023-12-31 | 1.25 |
| 2023-09-30 | 2.19 |
| 2023-06-30 | 3.70 |
| 2023-03-31 | 3.50 |
| 2022-12-31 | 6.59 |
| 2022-09-30 | 8.39 |
| 2022-06-30 | 10.01 |
| 2022-03-31 | 9.92 |
| 2021-12-31 | 17.36 |
| 2021-09-30 | 29.06 |
| 2021-06-30 | 0.25 |
| 2021-03-31 | 0.21 |
| 2020-12-31 | 0.47 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
